---
schema_version: "secwatch.filing_event.v1"
accession: "0000914475-26-000029"
form_type: "8-K"
ticker: "NBIX"
cik: "0000914475"
company_name: "NEUROCRINE BIOSCIENCES INC"
filed_at: "2026-05-28T20:01:33+00:00"
generated_at: "2026-05-28T21:25:56.852939+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Neurocrine annual meeting re-elects three directors, approves equity plan and auditor

## Summary
- Re-elected Class III directors Kevin C. Gorman, Gary A. Lyons, and Johanna Mercier with over 76M votes each.
- Advisory vote on named executive officer compensation approved: 78.99M for, 5.67M against, 0.10M abstentions.
- Stockholders approved Amended 2025 Equity Incentive Plan: 79.13M for, 5.57M against, 0.07M abstentions.
- Ratified Ernst & Young as independent auditor for FY2026: 83.88M for, 6.17M against.

## SEC filing metadata
- accession: 0000914475-26-000029
- form_type: 8-K
- ticker: NBIX
- cik: 0000914475
- company_name: NEUROCRINE BIOSCIENCES INC
- filed_at: 2026-05-28T20:01:33+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/914475/000091447526000029/0000914475-26-000029-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/914475/000091447526000029/nbix-20260527.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000914475-26-000029
- JSON: https://secwatch.observer/filing/0000914475-26-000029.json
- Plain text: https://secwatch.observer/filing/0000914475-26-000029.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.